| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.072 | 0.02 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.02 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.02 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.02 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.073 | 0.02 |